Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Wallach

Showing results (351-360 of 457) with videos related to

Pageof 46
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1992
Selective decrease in cell surface expression and mRNA level of the 55-kDa tumor necrosis factor receptor during differentiation of HL-60 cells into macrophage-like but not granulocyte-like cellsR Winzen, D Wallach, H Engelmann, et al.
European Journal of Immunology|August 1, 1995
Functional discrepancies between tumor necrosis factor and lymphotoxin alpha explained by trimer stability and distinct receptor interactionsM Schuchmann, S Hess, P Bufler, et al.
Methods in Enzymology|January 1, 1981
Interferon-induced enzymes: microassays and their applications: purification and assay of (2'-5')-oligoadenylate synthetase and assay of 2'-phosphodiesteraseM Revel, D Wallach, G Merlin, et al.
Agents and Actions. Supplements|January 1, 1991
Soluble and cell surface receptors for tumor necrosis factorD Wallach, H Engelmann, Y Nophar, et al.
Blood|April 15, 1993
Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-alpha or -betaD Aderka, Y Maor, D Novick, et al.
BMJ Medicine|April 10, 2024
Characterization of accelerated approval status, trial endpoints and results, and recommendations in guidelines for oncology drug treatments from the National Comprehensive Cancer Network: cross sectional studyMaryam Mooghali, Aaron P Mitchell, Joshua J Skydel, et al.
Annual Review of Immunology|June 8, 1999
Tumor necrosis factor receptor and Fas signaling mechanismsD Wallach, E E Varfolomeev, N L Malinin, et al.
The EMBO Journal|April 16, 1999
A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in 'reverse signalling'A D Watts, N H Hunt, Y Wanigasekara, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1991
Implications for persistent chlamydial infections of phagocyte-microorganism interplayI Sarov, E Geron, Y Shemer-Avni, et al.
International Journal of Epidemiology|January 23, 2020
Vibration of effects in epidemiologic studies of alcohol consumption and breast cancer riskLingzhi Chu, John P A Ioannidis, Alex C Egilman, et al.
Pageof 46

Showing results (351-360 of 457) with videos related to

Sort By:
Pageof 46
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1992
Selective decrease in cell surface expression and mRNA level of the 55-kDa tumor necrosis factor receptor during differentiation of HL-60 cells into macrophage-like but not granulocyte-like cellsR Winzen, D Wallach, H Engelmann, et al.
European Journal of Immunology|August 1, 1995
Functional discrepancies between tumor necrosis factor and lymphotoxin alpha explained by trimer stability and distinct receptor interactionsM Schuchmann, S Hess, P Bufler, et al.
Methods in Enzymology|January 1, 1981
Interferon-induced enzymes: microassays and their applications: purification and assay of (2'-5')-oligoadenylate synthetase and assay of 2'-phosphodiesteraseM Revel, D Wallach, G Merlin, et al.
Agents and Actions. Supplements|January 1, 1991
Soluble and cell surface receptors for tumor necrosis factorD Wallach, H Engelmann, Y Nophar, et al.
Blood|April 15, 1993
Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-alpha or -betaD Aderka, Y Maor, D Novick, et al.
BMJ Medicine|April 10, 2024
Characterization of accelerated approval status, trial endpoints and results, and recommendations in guidelines for oncology drug treatments from the National Comprehensive Cancer Network: cross sectional studyMaryam Mooghali, Aaron P Mitchell, Joshua J Skydel, et al.
Annual Review of Immunology|June 8, 1999
Tumor necrosis factor receptor and Fas signaling mechanismsD Wallach, E E Varfolomeev, N L Malinin, et al.
The EMBO Journal|April 16, 1999
A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in 'reverse signalling'A D Watts, N H Hunt, Y Wanigasekara, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1991
Implications for persistent chlamydial infections of phagocyte-microorganism interplayI Sarov, E Geron, Y Shemer-Avni, et al.
International Journal of Epidemiology|January 23, 2020
Vibration of effects in epidemiologic studies of alcohol consumption and breast cancer riskLingzhi Chu, John P A Ioannidis, Alex C Egilman, et al.
Pageof 46